Cleveland Clinic Lerner Research Institute
Cleveland Clinic Lerner Research Institute
Cleveland Clinic Lerner Research Institute
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
22<br />
L e r n e r R e s e a r c h I n s t i t u t e<br />
The Fight Against Blindness<br />
Areas of research: inherited retinal diseases, glaucoma, macular<br />
degeneration, corneal repair and transplantation, retinal physiology,<br />
diabetic retinopathy, and vision restoration<br />
Recent Landmark Discoveries in Ophthalmic <strong>Research</strong><br />
• Identified oxidative protein modifications in ocular tissues and plasma that may contribute to age-related<br />
macular degeneration (AMD) and provide biomarkers of AMD risk and susceptibility<br />
• Generated an AMD-like phenotype in mice immunized with lipid-derived oxidative protein modifications<br />
• Prevented oxygen-induced retinopathy, similar to a retinal disease of severely premature infants, in a model<br />
using a drug that blocks the loss of hypoxia-inducible factor<br />
“We are mapping out the early events<br />
that may cause macular degeneration,<br />
the most common type of blindness in<br />
our aging population, which may lead<br />
to novel treatments.”<br />
Joe Hollyfield, PhD<br />
Cole Eye <strong>Institute</strong><br />
Vascularization of the eye<br />
Macular degeneration of the eye<br />
“Oxygen-induced retinopathy is characterized<br />
by an area of central blood vessel<br />
loss (arrow, top figure). We found that<br />
injection of human umbilical cord blood<br />
derived CD133+ progenitor cells rescued<br />
retinal damage by promoting repair of<br />
the vasculature (bottom figure).”<br />
Bela Anand-Apte, MBBS, PhD<br />
Cole Eye <strong>Institute</strong>